The most direct way to validate aircraft wastewater surveillance is to run both systems simultaneously — wastewater testing and clinical passenger swabs — and see how they compare. That is exactly what researchers in Israel did in May 2022, and the results are among the most compelling in the field.

The design

During May 2022, Israeli researchers collected and tested wastewater from 86 international flights arriving from the United Kingdom and the United States [1]. For the same flights, arriving passengers underwent mandatory clinical testing — nasal or throat swabs processed through standard RT-PCR. This gave researchers two parallel datasets for the same population: the wastewater signal from the aircraft holding tank, and the individual test results from the passengers who produced it.

The timing was significant. May 2022 was a period when Omicron BA.2, BA.4, and BA.5 were the dominant circulating variants, and when mandatory border testing was still in place in Israel — meaning the clinical dataset was comprehensive rather than voluntary or incomplete.

The numbers

The wastewater results were striking: SARS-CoV-2 RNA was detected in over 90% of aircraft wastewater samples, across 86 flights [1].

The clinical results were not. The infection prevalence among passengers on those same flights was only 1.8% to 3.4% — meaning that on any given flight, only 1 or 2 passengers in every 50 to 100 actually tested positive for COVID-19.

The wastewater, in other words, was detecting pathogen signal with greater than 90% consistency across flights where the passenger-level infection rate was well under 5%.

This is the core demonstration of why the two methods are not equivalent — and why wastewater is the more powerful epidemiological tool for border surveillance.

How this is possible

The mechanism is elegant. Even at 2% passenger infection prevalence, 300 passengers on a long-haul flight means 6 infected individuals. Each of those individuals is shedding virus into the lavatory system throughout the flight. That waste is mixed, concentrated, and held in a tank. When the lab tests a single liter from that tank, it is effectively testing the pooled biological output of all 300 passengers.

The sensitivity advantage is the same logic that makes community wastewater surveillance able to detect COVID-19 when fewer than 1 in 1,000 residents are infected: concentration and pooling create a much lower detection threshold than individual testing allows.

The sequencing correlation

What makes this study more than just a detection comparison is the sequencing component. For positive wastewater samples, the researchers performed whole-genome sequencing to characterize which SARS-CoV-2 variants were present. They then compared the variant composition of the wastewater to the variant composition of the positive individual passenger swabs from the same flights.

The correlation was strong: r = 0.84 to 0.86 depending on the comparison [1]. The Omicron sub-lineages detected in the wastewater matched what was circulating in the passengers, and in similar proportions.

This is the critical validation. It means wastewater does not just detect that SARS-CoV-2 is present — it detects which variant is present, with sufficient accuracy to inform public health decisions about variant emergence and monitoring.

The wastewater is not an approximation of the passenger population. It is the passenger population — biologically pooled, genetically readable, and sampled without asking a single person to participate.

The path beyond border testing

The study's authors made an explicit projection: if the statistical relationship between wastewater viral load and passenger infection rate holds, it may be possible to model infection prevalence in arriving passenger populations using wastewater data alone.

This is not a minor result. It means that mandatory border testing — with all of its friction, cost, compliance challenges, and trade implications — could potentially be replaced by a passive wastewater monitoring system that provides equivalent or better epidemiological information without any passenger interaction.

For countries like Thailand, where maintaining seamless border flow while protecting public health is an explicit policy goal, this is the precise trade-off the Israel study illuminates.